Medical Properties Trust, Inc. (MPW)
NYSE: MPW · IEX Real-Time Price · USD
4.800
+0.090 (1.91%)
At close: Jul 19, 2024, 4:00 PM
4.840
+0.040 (0.83%)
Pre-market: Jul 22, 2024, 7:13 AM EDT
Medical Properties Trust Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for MPW stock have an average target of 5.68, with a low estimate of 4.00 and a high estimate of 10. The average target predicts an increase of 18.33% from the current stock price of 4.80.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for MPW stock from 13 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 3 | 3 | 3 | 2 | 2 | 1 |
| Hold | 4 | 4 | 6 | 7 | 7 | 8 |
| Sell | 4 | 4 | 4 | 4 | 4 | 4 |
| Strong Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 13 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Exane BNP Paribas | Exane BNP Paribas | Buy → Hold Downgrades $6 → $4 | Buy → Hold | Downgrades | $6 → $4 | -16.67% | Jul 2, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $4.5 → $5 | Hold | Maintains | $4.5 → $5 | +4.17% | May 30, 2024 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $5 | Buy → Hold | Downgrades | $5 | +4.17% | May 14, 2024 |
| Deutsche Bank | Deutsche Bank | Strong Sell → Hold Upgrades $2 → $5 | Strong Sell → Hold | Upgrades | $2 → $5 | +4.17% | Apr 17, 2024 |
| Colliers Securities | Colliers Securities | Hold Maintains $4.25 → $5 | Hold | Maintains | $4.25 → $5 | +4.17% | Apr 15, 2024 |
Financial Forecast
Revenue This Year
984.65M
from 871.80M
Increased by 12.94%
Revenue Next Year
980.40M
from 984.65M
Decreased by -0.43%
EPS This Year
-0.33
from -0.93
EPS Next Year
0.45
from -0.33
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.1B | 1.1B | 1.1B | 1.0B | 994.7M |
| Avg | 984.7M | 980.4M | 943.1M | 910.4M | 956.8M |
| Low | 795.5M | 690.4M | 827.4M | 842.4M | 928.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 25.8% | 14.5% | 9.8% | 9.3% | 9.3% |
| Avg | 12.9% | -0.4% | -3.8% | -3.5% | 5.1% |
| Low | -8.7% | -29.9% | -15.6% | -10.7% | 2.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.49 | 0.58 | 0.44 |
| Avg | -0.33 | 0.45 | 0.35 |
| Low | -1.01 | 0.34 | 0.26 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | -1.9% |
| Avg | - | - | -22.5% |
| Low | - | - | -41.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.